DALLAS, March 15, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Star Scientific Inc. (Nasdaq:CIGX). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at:
Star Scientific Inc. (CIGX) is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured tobacco curing technology. StarCured interferes with the formation of tobacco specific nitrosamines (TSNAs) that occurs in traditional curing methods. The Company markets dissolvable hard smokeless tobacco products made with tobacco that is 100% Virginia StarCured tobacco, with TSNA levels that it believes are the lowest anywhere in the world. Its subsidiary, Rock Creek Pharmaceuticals Inc., is involved in the development of nutraceuticals as well as products to address neurological and mood disorders.
For only $39 a month, you can sign up for our real-time stock alert service. Click here to join now:
In the report, the analyst notes:
"Shares of CIGX jumped 18% Monday, extending a surge on Friday as the tobacco company announced it received two notices and letters from the U.S. Patent & Trademark Office (USPTO) confirming the validity of each of the claims involved in the reexamination of the '649 and '401 patents. These patents are central to a patent infringement case filed by CIGX against North Carolina-based tobacco giant RJ Reynolds Tobacco Company Inc. (RJR) in 2001 and 2002."
"CIGX currently awaits a ruling from the U.S. Court of Appeals on its appeal of the June 2009 jury verdict in favor of RJR. Oral argument on the appeal was heard by a three-judge panel of that Court on January 11, 2011. The appeal requests that the jury verdict be reversed, the case remanded to U.S. District Court for a new trial, and that it be reassigned to a new judge."
To read the entire report visit:
See what investors are saying about CIGX at
Get breaking news on CIGX at
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit:
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.
CONTACT: Brian Johnson email@example.com 1-888-307-2850